The Economic impact of ME/CFS: Individual and societal costs
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: ME/CFS is characterized by debilitating fatigue in addition to other physical and cognitive symptoms. It is estimated to affect over 800,000 adults in the U.S. ME/CFS often results in diminished functionality and increased economic impact. The economic impact of an illness is generally divided into two categories: direct and indirect costs. Despite high prevalence rates and the disabling nature of the illness, few studies have examined the costs of ME/CFS at the individual and societal level. In fact, of the four studies examining the economic impact of ME/ME/CFS only two used a U. S. sample. The current study used community and tertiary samples to examine the direct costs of ME/CFS. METHODS: Using archival data, Study 1 examined the direct cost of ME/CFS in a community-based sample in Chicago. Study 2 estimated the direct cost of ME/CFS in a tertiary sample in Chicago. Both Study 1 and Study 2 assessed direct costs using office visit costs, medical test costs, and medication costs. RESULTS: For Study 1, the annual direct total cost per ME/CFS patient was estimated to be $2,342, with the total annual direct cost of ME/CFS to society being approximately $2 billion. In Study 2, the annual direct was estimated to be $8,675 per ME/CFS patient, with the total annual direct cost of ME/CFS to society being approximately $7 billion. CONCLUSION: Using ME/CFS prevalence data of 0.42 and indirect costs estimates from Reynolds et al. (2004), the direct and indirect cost of ME/CFS to society was estimated to be $18,677,912,000 for the community sample and $23,972,300,000 for the tertiary sample. These findings indicate that whether or not individuals are recruited from a community or tertiary sample, ME/CFS imposes substantial economic costs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study
Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M. C., Dobbins, J. G., Komaroff, A., & and International Chronic Fatigue Syndrome Study Group. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-12-199412150-00009 · Cited by 4,969 · cited 10×
“This illness is has more recently been referred to as ME/ CFS (where ME stands for either Myalgic Encephalomyelitis or Myalgic Encephalopathy).”
BackgroundMethodInfluentialA community-based study of chronic fatigue syndrome.
Jason, L. A., Richman, J. A., Rademaker, A. W., Jordan, K. M., Plioplys, A. V., Taylor, R. R., McCready, W., Huang, C.-F., & Plioplys, S. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.18.2129 · Cited by 811 · cited 3×
“[1] estimates that more than 800,000 adults in the United States have ME/CFS.”
BackgroundInfluentialSelf-citationChronic Fatigue, Chronic Fatigue Syndrome, and Fibromyalgia: Disability and Health-Care Use
BOMBARDIER, C. H., & BUCHWALD, D. (1996) · Medical Care · doi:10.1097/00005650-199609000-00005 · Cited by 211 · cited 3×
“Bombardier and Buchwald [5] examined the direct cost of patients with ME/CFS in the United States using patients from a referral clinic.”
BackgroundResult
Cited by
Nacul, L. C., Lacerda, E. M., Pheby, D., Campion, P., Molokhia, M., Fayyaz, S., Leite, J. C., Poland, F., Howe, A., & Drachler, M. L. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-91 · Cited by 255
“Despite the lower disease frequency we found compared to some other studies [30-34,39-41], the consequences for health and social care are still considerable, given the disabling nature of ME/CFS and the high economic impact for patients, families and the wider society [15,44,45].”
A formal analysis of cytokine networks in chronic fatigue syndrome
Broderick, G., Fuite, J., Kreitz, A., Vernon, S. D., Klimas, N., & Fletcher, M. A. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.04.012 · Cited by 202
“Costs to the US economy are estimated at $9.1 billion in lost productivity (Reynolds et al., 2004) and up to $24 billion dollars in health care expenditures annually (Jason et al., 2008).”
BackgroundInfluentialShukla, S. K., Cook, D., Meyer, J., Vernon, S. D., Le, T., Clevidence, D., Robertson, C. E., Schrodi, S. J., Yale, S., & Frank, D. N. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145453 · Cited by 137
Nacul, L. C., Lacerda, E. M., Campion, P., Pheby, D., Drachler, M. D. L., Leite, J. C., Poland, F., Howe, A., Fayyaz, S., & Molokhia, M. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-402 · Cited by 117
“Discussion ME/CFS is a disabling condition with a high impact on individuals and society, which causes a substantial economic burden [28].”
BackgroundAssociation of catastrophizing and fatigue: A systematic review
Lukkahatai, N., & Saligan, L. N. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2012.11.006 · Cited by 96
Metadata
- Authors
- Jason, L. A., Benton, M. C., Valentine, L., Johnson, A., & Torres-Harding, S.
- Venue
- Dynamic Medicine
- Published
- 2008-04-08
- Volume
- 7
- Issue
- 1
- Pages
- 6-6
- ISSN
- 1476-5918 (ISSN-L)
- OpenAlex
- W2037024023
- Cited by
- 174
- References
- 3
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Economic impact of ME/CFS: Individual and societal costs. https://app.cochat.ai/papers/10.1186/1476-5918-7-6
- The paper
- Jason, L. A., Benton, M. C., Valentine, L., Johnson, A., & Torres-Harding, S. (2008). The Economic impact of ME/CFS: Individual and societal costs. Dynamic Medicine. https://doi.org/10.1186/1476-5918-7-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.